allcancercure.com

A group of scientists led by Professor Xavier Pares of the Department of Biochemistry and Molecular Biology at Universitat Autonoma de Barcelona, has published research on AKR1B10, an enzyme that is detected in large quantities only in lung cancers, particularly those caused by smoking. This enzyme can appear even when the cancer has not yet [...]

One of the deadliest forms of cancer appears to carry a specific weakness.
When a key gene called 14-3-3zeta is silenced, lung cancer cells can’t survive on their own, researchers have found.
The gene is a potential target for selective anti-cancer drugs, says Haian Fu, PhD, professor of pharmacology, hematology & oncology at Emory University School of [...]

Hayley McDaid, Ph.D. assistant professor of medicine and of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, has received a $100,000 grant from Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer for her research of lung cancer. The grant, which is being funded equally over two years by Joan’s Legacy [...]

Lack of sunlight may increase the risk of lung cancer, suggests a study of rates of the disease in over 100 countries, published in the Journal of Epidemiology and Community Health.
Lung cancer kills over a million people every year around the globe.
The researchers looked at the association between latitude, exposure to ultraviolet B (UVB) light, [...]

By simply eating four or more servings of green salad a week and working in the garden once or twice a week, smokers and nonsmokers alike may be able to substantially reduce the risk of developing lung cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.
“This is the first risk prediction [...]

New research from The University of Nottingham has pinpointed a potential early warning system for lung cancer.
The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent. Early diagnosis means [...]

Positron emission tomography (PET) is a useful diagnostic tool that supports the need for more accurate staging of lung cancer and improved treatment for patients, concludes an extensive systematic review published online yesterday in Journal of National Cancer Institute.
The review conducted by the Lung Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based [...]

Cleveland Clinic and Riverain Medical announced the establishment of the first study in an ongoing program to determine whether chest X-ray CAD (computer-aided detection) can improve practical early detection of lung cancer. The program is designed to determine whether chest X-ray CAD can help identify hard to detect lung cancers at an early stage when [...]

Pharsight Corporation (OTC Bulletin Board: PHRS), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, announced that its Strategic Consulting Services Group is using a quantitative disease model developed by the Food and Drug Administration (FDA) for non-small cell lung cancer (NSCLC) to support an oncology drug development program [...]